A 16-year-old becomes unresponsive and experiences three generalized tonic-clonic seizures four days after giving birth to a healthy infant. This case study reveals key knowns and unknowns in pediatric demyelinating disease.Read More
Switching Disease-Modifying Therapies in Pediatric Multiple Sclerosis: Insights From Real-World Data
For young patients on platform injectable disease-modifying therapy (DMT), switching to an oral or infusion DMT was associated with lower relapse rates compared with switching to another injectable DMT.
Study Spotlights Need for Mental Health Monitoring in Pediatric Epilepsy, Especially for Minority Youth
Reporting of suicidal thoughts is four times higher in pediatric patients with epilepsy relative to overall pediatric patients, according to recent Cleveland Clinic screening data.
Making Pediatrics More of a Priority in Multiple Sclerosis Treatment Trials
A narrative review outlines the need for earlier and broader pediatric trial enrollment while profiling a few ongoing studies and other signs of potential progress.
Surgical Candidates for Pediatric Epileptic Spasms Can Be Selected Without Invasive Monitoring
Using an MRI-based strategy to select children with epileptic spasms for surgery yields seizure-free outcomes comparable to those with a strategy that includes intracranial monitoring, a new study shows.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy